ALGOSOURCE

The AlgoSource group, a recognised world expert in microalgae, offers a complete range of services from production engineering to the industrial valorisation of microalgae. Its unique know-how covers all the processes involved in the production and transformation of microalgae and provides an integrated vision for its industrial clients.

AlgoSource is developing 4 main areas for its industrial clients and consumers:

  • Production of microalgae in controlled systems (photobioreactors)
  • Biorefinery engineering (custom extraction of molecules)
  • Production and sale of natural products "made in France" (see our Alpha Biotech shop)
  • Integrated system design (design of photobioreactors from 1 litre to several m3)

Olivier Lépine's speech at Biomim'expo 2018:

Other videos :


Releases :

L'Echos de la presqu'île / 25 FEB 2019 / Saint-Nazaire: With its micro-algae, Algo Source is thinking bigger

Les Echos / 29 JANV 2019 / AlgoSource bets on spirulina

OUEST FRANCE / 24 JAN 2019 / Agriculture. The algae breeding start-up sees life in green in Saint-Nazaire

OUEST FRANCE / 17 APR 2018 / In Saint-Nazaire, micro-algae could make the port greener

other news


Website


Contact:

ADV TECH

Adv Tech was founded in 2012. We develop new rotor technologies, based on trochoidal motion. These technologies can be applied to thrusters, wind turbines and tidal turbines, with exceptional advantages.

Everyone in the company has their own speciality and specific skills, but we are all focused on a common goal: to make high-efficiency propulsion and renewable energies cheaper, safer and easier to promote.


Press releases :

20 MINUTES / 03 FEB 2020 / Bordeaux: The start-up ADV-Tech experiments with a unique urban wind turbine

ADV-Tech has just signed a partnership with Bordeaux Métropole Energies to test an urban wind turbine whose revolutionary technology allows for very high efficiency, without the blades making the slightest noise.

BOATS.COM /16 OCT 2019 / ADV Tech: a revolutionary propeller to replace the propeller?

Could the new biomimetic rotor developed by ADV Tech replace our good old propellers in the same way that propellers replaced paddle wheels? This question was asked after a demonstration on the water of a floating drone equipped with this new propulsion system.

ENGIE INNOVATION / 03 JUL 2017 / ADV Tech's revolutionary wind turbine

... more


Website


Contact:

ADV Tech, Esplanade des Arts et Métiers, 33400 TALENCE

contact@adv-tech.fr

Arnaud Curutchet, Founder

LinkedIn

 

GLOWEE

A living material that produces light

We are developing a bioluminescent raw material made from natural and infinitely cultivable micro-organisms. Our core business is biotechnology. We improve (without genetic modification) these micro-organisms to make them more efficient in terms of light production (intensity, stability, efficiency).

Sustainable light systems for the landscape of tomorrow

In collaboration with energy companies, real estate groups, architects, local authorities, artists, construction companies, landscapers and hotels, Glowee meets your sustainable lighting needs.

Let's create together the uses of bioluminescence of tomorrow!


 

Videos :


The board Biomim'review :

 


Releases :

Ministry of Agriculture / 14 NOV 2018 / Glowee: producing light without electricity

Les Echos / 03 SEPT 2019 / Crowdfunding: how Glowee raised over €1.3 million

FUTURA PLANET / 17 MAY 2017 / Bioluminescence: Introducing Glowee, an electricity-free biological light

LABIOTECH / 20 NOV 2019 / 39M Series B to Fund Biopolymers for Surgery and Implants

other news


Website


Contact:

 contact@glowee.com

BATHY BOT

The artificial coloniser in the deep environment.
An underwater nursery that will be immersed in the Mediterranean Sea by the Ifremer Nautile in spring 2020.
A collective project, supported by :
  • Christian Tamburini, M I OHDR CNRS, scientific project leader
  • Jacques Rougerie, Jacques Rougerie Foundation
  • Olivier Bocquet, Tangram Architects and Tangram Lab
  • TREEX and the Jacques Rougerie Foundation have produced the design of the colonizer
  • Guillaume Terrasse, VICAT
  • and Amaury Thomas, SOLIQUID, for 3D printing

Presentation at Biomim'expo 2019:


 

CERAMIC LABORATORY SAINT GOBAIN/CNRS

The Ceramic Synthesis and Functionalization Laboratory is a joint CNRS / Saint-Gobain research unit, doing fundamental research on functional ceramic materials, in particular ceramic materials having charge transfer properties. More specifically, we study how the combination of functional properties can lead to innovative materials.
We focus on three scientific topics:
  • Control the hierarchic porosity in the materials
  • Control the microstructure of ceramic materials at the grain scale in order to optimise their functional properties (including ionic conductivity)
  • Understand the interaction of the surface of ion-conducting materials with gaseous reactive species

The board Biomim'review


Sylvain Deville's presentation at Biomim'expo 2016 : (à 28:00)


Publications : here


Website


Contact: here

CORWAVE

CorWave develops innovative implantable cardiac pumps based on a breakthrough technology: the undulating membrane.

The CorWave corrugated membrane offers a novel approach in cardiac assist to provide true pulsatile blood flow.

CorWave is a fast-growing medical device company that develops novel cardiac assist pumps to provide reliable and sustainable solution to the major public health issue ofheart failure. The solutions developed by CorWave, which are truly physiological, will ensure better life to patients.

Founded in 2011 by the incubator MD Start and supported by renowned investors, CorWave has obtained over €35 million in funding and employs more than 50 employees.

CorWave has won numerous awards and competitions. In 2016 CorWave won phase 1 of the Global Innovation Contest (GIC) for the NovaPulse project. In 2017, this project also won phase 2 of the CMI competition. The same year, CorWave received the Deloitte Technology Fast 50 Biotech of the Future award, and in 2018 received support for the Calypso programme under the Programme d'Investissements d'Avenir (PIA) operated by Bpifrance.


Videos :


News and press review :

L'USINE NOUVELLE / 14 APR 2018 / CorWave develops innovative cardiac assist technology

LA TRIBUNE / 14 MAY 2019 / Public Choice Award 2018, CorWave accelerates towards clinical trials

CHALLENGES / 08 NOV 2016 / CorWave, an exciting fundraising

... more


Website


Contact:

M2I LIFE SCIENCES

 

M2i Life Sciences is an industrial player in the chemical industry, active in the animal and plant bio-control sector as well as in the field of human health. Biocontrol is the set of biological protection methods that replicate intra-species behaviours and natural mechanisms of regulation of bio-aggressors.

M2i Life Sciences is a world leader in pheromones for crop protection and animal health.

We master :

  • The synthesis of pheromonal molecules
  • The production of these pheromones from gram to ton
  • The formulation of these pheromones and the delivery systems
  • Design and production of finished products

We combine R&D know-how, a production plant and a manufacturing centre for finished products, which allows us to control the entire product development cycle and to integrate innovation at every stage of its design.


The intervention of Johann Fournil at Biomim'expo 2019 :

The board Biomim'review :


Releases :

ActuLot / 27 JUNE 2020 / In Parnac, M2i launches a unique production for biological crop protection

INFO CHEMISTRY / 31 MAR 2020 / Exclusive interview with Philippe Guerret, President of M2i Life Sciences

The Tribune / 09 SEP 2019 / M2i, French biocontrol expert, raises €60 million

USINE NOUVELLE / 03 SEP 2019 / M2i Life Sciences raises €60 million to support its strong growth in AgTech

Chemistry News / 04 SEP 2019 / Biocontrol: French company M2i raises €60 million

L'USINE NOUVELLE / 5 NOV 2019 / M2i Life Sciences named Start-up of the Year 2019 by L'Usine Nouvelle


Website


Contact:

  • M2i Life Sciences
    1, rue royale
    112 Hill Offices Building G1 - Ground Floor 1
    92 213 Saint-Cloud Cedex
    France
  • tel-icon+33 1 85 74 09 29

TISSIUM

A NEW ERA OF RECONSTRUCTIVE POLYMERS

TISSIUM™ invents the next generation of synthetic polymers for tissue reconstruction :

  • BIOMORPHIC : Conforms to and integrates with surrounding tissue to enable natural healing
  • PROGRAMMABLE : Modular polymer design can be adjusted to match tissue-specific requirements

TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.

Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.

Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices.

We have developed a fully integrated innovation, design, commercialisation and manufacturing platform to support our internal programmes as well as co-development partnerships with leaders in the medtech industry.


Maria Pereira's intervention at Biomim'expo 2019:


The board Biomim'review :

 


Releases :

Les Echos / 20 NOV 2019 / Tissium raises €39 million for its programmable surgical polymers

BFM BUSINESS / 21 NOV 2019 / French start-up Tissium, which wants to repair human tissue, raises €39 million

SOFINNOVA / 20 NOV 2019 / TISSIUM Closes €39M Series B Funding Round

LABIOTECH / 20 NOV 2019 / 39M Series B to Fund Biopolymers for Surgery and Implants

other news


Website


Contact:

MYCOPHYTO

MYCOPHYTO was co-founded in 2017 by Justine LIPUMA, a doctor in microbiology, and Christine PONCET, an agricultural engineer. Spin off INRAE (INRA) and UCA (Université Côte d'Azur), it has received more than 12 awards since its creation.

MYCOPHYTO is to develop, produce and propose to agricultural professionals effective biological solutions by adapting scientific knowledge concerning mycorrhizal symbiosis.

MYCOPHYTO, an INRAE and UCA spin-off, integrates the latest knowledge from life sciences and technological innovations. The start-up has patented solutions for the implementation of native arbuscular mycorrhizal fungi (AMFs) in crops to recreate sustainable natural synergies with plant roots.

MYCOPHYTO is based on a dynamic of key players including: world-renowned scientists, joint research structures, technical and training institutes and farmer ambassadors.


Videos :


Other releases :

LA TRIBUNE / 18 MAR 2020 / Mycophyto, the proof-of-concept deeptech

BPI FRANCE / 19 NOV 2019 / Mycophyto: Agriculture transformed by science

HORIZONS / 17 DEC 2019 / Mycophyto, the natural alternative to pesticides that increases yields

CREDIT AGRICOLE INFO / 21 OCT 2019 / Mycophyto, a natural and tailor-made alternative to chemical inputs

FRENCH WEB / 25 SEP 2019 / Startup Mycophyto raises €1.4 million to offer an organic alternative to pesticides


Website


Contact:

Justine LIPUMA, Co-Founder & CEO
540 avenue de la Plaine
06250 Mougins
contact@mycophyto.fr

PROPHESIS

REVEALS THE INVISIBLE

With the world's most advanced neuromorphic vision systems, inspired by human vision and built on the foundation of neuromorphic engineering.

PROPHESEE is the revolutionary system that gives Metavision to machines, revealing what was previously invisible to them.

Prophesee is the inventor of the world's most advanced neuromorphic vision systems.

Inspired by human vision, Prophesee's technology uses a patented sensor design and AI algorithms that mimic the eye and brain to reveal what was invisible until now using standard frame-based technology.

Prophesee's machine vision systems open new potential in areas such as autonomous vehicles, industrial automation, IoT, security and surveillance, and AR/VR. One early application was in medical devices that restore vision to the blind.

Prophesee's technology is fundamentally different from the traditional image sensors - it introduces a paradigm shift in computer visionevent-based vision.


Guillaume Butin's presentation at Biomim'expo 2019:


The board Biomim'review :


Other releases :

BFM Business 26 FEB 2020 : Sony acquires stake in French company Prophesee to further develop machine vision

Engineering techniques 18 MAR 2020 : Prophesee develops neuromorphic vision sensors

Les Echos Entrepreneurs 28 OCT 2019 : Prophesee secures €25 million and deploys its sensors in industry

The Tribune 28 OCT 2019: Deeptech Prophesee raises €25 million to give sight to the blind and to machines

Le Figaro 28 OCT 2019: Prophesee raises 25 million and shows new ambitions

VB 28 OCT 2019 : Prophesee raises $28 million for machine vision sensors that mimic the human eye


Website


Contact:

Guillaume Butin | Marketing Communications Director

gbutin@prophesee.ai | +33 (0) 6 63 87 26 39